Overview
Ameloblastic carcinoma is a very rare and aggressive type of cancer that develops in the jawbones. It arises from the cells that normally form tooth enamel, called ameloblasts. Unlike its benign counterpart (ameloblastoma), ameloblastic carcinoma is a true malignancy, meaning it can invade surrounding tissues and spread (metastasize) to other parts of the body, including the lungs and lymph nodes. The tumor most commonly affects the lower jaw (mandible) but can also occur in the upper jaw (maxilla). Patients typically notice a growing mass or swelling in the jaw that may be painful. Teeth in the affected area may become loose, and there can be difficulty chewing, opening the mouth, or numbness in the lip or chin. The tumor can sometimes develop from a pre-existing ameloblastoma that transforms into cancer, or it can arise on its own without any prior benign tumor. Treatment usually involves surgery to remove the tumor with wide margins of healthy tissue. Radiation therapy and chemotherapy may be used in addition to surgery, especially if the cancer has spread or cannot be completely removed. Because this cancer is so rare, there are no standardized chemotherapy protocols, and treatment plans are often individualized. Long-term follow-up is essential because the tumor has a significant risk of coming back (recurrence) even after treatment. Early diagnosis and aggressive surgical management offer the best chance for a favorable outcome.
Key symptoms:
Swelling or lump in the jawJaw painLoose teeth without an obvious causeDifficulty opening the mouthNumbness or tingling in the lip, chin, or gumsDifficulty chewing or swallowingA non-healing sore or ulcer in the mouthFacial asymmetry or visible deformityBleeding from the gums or mouthRapid growth of a previously stable jaw massSwollen lymph nodes in the neckWeight lossNasal obstruction if the upper jaw is involved
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Ameloblastic carcinoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ameloblastic carcinoma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesSandostatin LAR
Novartis Pharmaceuticals Corporation
Sandostatin LAR Patient Support (Novartis Patient Assistance)
Travel Grants
No travel grants are currently matched to Ameloblastic carcinoma.
Community
No community posts yet. Be the first to share your experience with Ameloblastic carcinoma.
Start the conversation →Latest news about Ameloblastic carcinoma
No recent news articles for Ameloblastic carcinoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my ameloblastic carcinoma, and has it spread beyond the jaw?,What type of surgery do you recommend, and how much of the jaw will need to be removed?,Will I need radiation therapy or chemotherapy after surgery?,What are the options for jaw reconstruction and dental rehabilitation?,Has my tumor been tested for BRAF or other mutations that might guide treatment?,How often will I need follow-up imaging, and for how long?,Are there any clinical trials available for ameloblastic carcinoma that I might be eligible for?
Common questions about Ameloblastic carcinoma
What is Ameloblastic carcinoma?
Ameloblastic carcinoma is a very rare and aggressive type of cancer that develops in the jawbones. It arises from the cells that normally form tooth enamel, called ameloblasts. Unlike its benign counterpart (ameloblastoma), ameloblastic carcinoma is a true malignancy, meaning it can invade surrounding tissues and spread (metastasize) to other parts of the body, including the lungs and lymph nodes. The tumor most commonly affects the lower jaw (mandible) but can also occur in the upper jaw (maxilla). Patients typically notice a growing mass or swelling in the jaw that may be painful. Teeth in
How is Ameloblastic carcinoma inherited?
Ameloblastic carcinoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ameloblastic carcinoma typically begin?
Typical onset of Ameloblastic carcinoma is adult. Age of onset can vary across affected individuals.
Which specialists treat Ameloblastic carcinoma?
15 specialists and care centers treating Ameloblastic carcinoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Ameloblastic carcinoma?
1 patient support program are currently tracked on UniteRare for Ameloblastic carcinoma. See the treatments and support programs sections for copay assistance, eligibility, and contact details.